Bavarian Biotech Report 2011/2012 (7MB) - Bio M
Bavarian Biotech Report 2011/2012 (7MB) - Bio M Bavarian Biotech Report 2011/2012 (7MB) - Bio M
Dynamic BiosensorsBIOTECH DNA/PROTEIN ANALYTICSContact:Dr. Dirk SchollLichtenbergstraße 4D-85748 GarchingPhone: +49 (0) 89 289-11490Fax: +49 (0) 89 289-12704E-Mail: info@dynamic-biosensors.comInternet: www.dynamic-biosensors.comKeywords: Vaccines, Small Molecules, Peptide/Protein, Antibody, Proteomics,Chip / Array TechnologyDynamic Biosensors offers a superior new analysis system for molecularinteraction. Based on the revolutionary label-free switchSENSE technology,we allow researchers to determine affinity and kinetics of molecular interactionswith unrivaled sensitivity in real time. As a total novelty in label-freeanalysis, switchSENSE allows to determine molecular size (e.g. formationof aggregates) and conformational changes in real-time as well. WhileswitchSENSE is an extremely versatile technology, our current focus lies onprotein interaction analysis (antibodies and transcription factors), proteinfolding and posttranslational modifications.Contact:PD. Dr. Hans-Peter KlenkPoeckinger Fussweg 7aD-82340 FeldafingPhone: +49 (0) 8157 9963-164Fax: +49 (0) 8157 9963-162E-Mail: info@egene-biotech.deInternet: www.egene-biotech.dee.gene Biotechnologie GmbHBIOTECH BIOINFORMATICSKeywords: Pharmacogenomics, Genomicse.gene Biotechnologie GmbH is a service provider in microbial genomicsand pharmacogenomics.We perform for our academic and industrial customers complete microbialgenome analyses from genome sequencing to annotation and pathwayreconstruction.ELLA Biotech GmbHBIOTECH THERAPEUTICS & DIAGNOSTICSContact:Dr. Peter FrischmannAm Klopferspitz 19D-82152 MartinsriedPhone: +49 (0) 89 70939316Fax: +49 (0) 89 70939440E-Mail: info@ellabiotech.comInternet: www.ellabiotech.comKeywords: Clinical Research, Antisense/Nucleotides, Genomics, RNAi &Antisense, Chip / Array Technology, PCR, Clinical DiagnosticsOur focus is the synthesis of special oligoribonucleotides for selected projectsin diagnostics, chip technologies, genesynthesis and further topics –following quality standards which you would appreciate and expect in yourown lab. The guidelines for the synthesis standards can be defined by ourcustomers themselves.Through our validated technology platform, our experienced interdisciplinaryteam and our resolute attitude towards the highest quality in our productswe offer tangible advantages to our customers and partners.56
Emergent Product DevelopmentGermany GmbHBIOTECH DNA/PROTEIN ANALYTICSKeywords: Vaccines, Infectious DiseasesEmergent BioSolutions protects and enhances life by developing and manufacturingvaccines and therapeutics that are supplied to healthcare providersand purchasers for use in preventing and treating disease. Emergent‘smarketed and investigational products target infectious diseases, oncologyand autoimmune disorders.Contact:Isabelle ErdeljiWalter-Gropius-Str. 17D-80807 MünchenPhone: +49 (0) 89 5506988-0Fax: +49 (0) 89 5506988-88E-Mail: erdeljii@ebsi.comInternet: www.emergentbiosolutions.comEMP GenetechBIOTECH DNA/PROTEIN ANALYTICSKeywords: Peptide/Protein, Clinical Diagnostics, Tissue Engineering / CellCulture, Drug DevelopmentEMP Genetech conducts development and production of recombinant proteinsas a service provider for research departments in industry and academia.For production HEK293 (hn embryonic kidney) cells are being used. Thesecells are distinguished for the expression of glycosilated, correctly processedand modified proteins. The expressed proteins show excellent bioactivitycompared to other expression systems. The biomolecules are produced inserum free culture medium of safe origin. EMP Genetech offers all workingsteps from cloning of the GOI to chromatographic purification of the producedprotein. There are developed stable cell lines of high productivity. Theseare cultivated as suspension cell cultures in stirred bioreactors usually in acontinous mode. The expression product is purified from cell supernatant orcell extract by classical column chromatographic methods. The bioactivitywill be analysed by enzymatic or cell assays.Contact:Dr. Franz X. WelserHebbelstr. 61D-85055 IngolstadtPhone: +49 (0) 841 3796013Fax: +49 (0) 841 8817185E-Mail: info@empgenetech.comInternet: www.empgenetech.comEntelechon GmbHBIOTECH DNA/PROTEIN ANALYTICSKeywords: Proteomics, Clinical Research, Chip / Array Technology, PCR,Genomics, Antibody Production ServiceEntelechon is a globally operating service provider specialized in advancedgenomics and proteomics projects. Success factor: Leveraging full potentialof gene and protein synthesis platforms as well as synergy of biochemistry,molecular biology and bioinformatics for implementation of complex projects.Services: Gene optimization and synthesis, protein expression invarious systems, protein analysis and quantification, design and synthesisof gene mutant libraries, bioinformatics software development.Applications: Preclinical stage drug discovery; protein engineering and production;development of therapeutic proteins, antibodies, vaccines, industrialenzymes; downstream biotech services; multiple profile research projects.Contact:Dr. Werner DeiningerIndustriestr. 1D-93077 Bad AbbachPhone: +49 (0) 9405 96999-10Fax: +49 (0) 9405 96999-28E-Mail: info@entelechon.comInternet: www.entelechon.com57
- Page 6 and 7: Select IMGM as your outsourcing par
- Page 8 and 9: The 2011 Biotech Year in Bavaria -A
- Page 10 and 11: Due to this focus that was establis
- Page 12 and 13: Furthermore, the continued interest
- Page 14 and 15: Last but not least, the IZB start-u
- Page 16 and 17: Company FoundationsMerck-Sharp & Do
- Page 18 and 19: Total number of employees in the Ba
- Page 20 and 21: PHASE II4SC: Hepatocellular carcino
- Page 22 and 23: Deals, Cooperation, Mergers, Financ
- Page 24 and 25: M&A-ActivityIn early 2011 the acqui
- Page 26: Due to the increasing number of new
- Page 29: one so called “innovation allianc
- Page 32 and 33: 4SC AGBIOTECH THERAPEUTICS & DIAGNO
- Page 34 and 35: Contact:Dr. Luc St-OngeFraunhoferst
- Page 36 and 37: Contact:Dr. Lars WassillWerkstr. 2D
- Page 38 and 39: Apceth GmbH & Co. KGBIOTECH THERAPE
- Page 40 and 41: Contact:Dr. Gundel HagerBahnhofstr.
- Page 42 and 43: Bernina Plus GmbHBIOTECH THERAPEUTI
- Page 44 and 45: Biontex Laboratories GmbHBIOTECH DE
- Page 46 and 47: Carl Zeiss MicroImaging GmbHBIOTECH
- Page 48 and 49: ChemDiv, Inc.CROContact:Dr. Anna Ni
- Page 50 and 51: conoGenetix biosciences GmbHBIOTECH
- Page 52 and 53: CoreLab Partners Europe GmbHCROCont
- Page 54 and 55: Davids Biotechnologie GmbHBIOTECH D
- Page 58 and 59: Contact:Uschi LangGoethestr. 4D-803
- Page 60 and 61: Eurofins MWG OperonBIOTECH DNA/PROT
- Page 62 and 63: FGK Clinical Research GmbHCROContac
- Page 64 and 65: GeneArt AGBIOTECHContact:Prof. Dr.
- Page 66 and 67: Contact:Dr. Korbinian GroteBayerstr
- Page 68 and 69: Contact:Peter Paul SchikoraMühlfel
- Page 70 and 71: Contact:Kurt MartinJosef-Engert-Str
- Page 72 and 73: ibidi GmbHBIOTECH DEVICES & REAGENT
- Page 74 and 75: Immumed GmbH -Gesellschaft für ang
- Page 76 and 77: INHECO GmbHBIOTECH DEVICES & REAGEN
- Page 78 and 79: IRIS Biotech GmbHPHARMA & CHEMICAL
- Page 80 and 81: KLIFOVET AGCROContact:Dr. Klaus Hel
- Page 82 and 83: LEUKOCARE AGBIOTECH DEVICES & REAGE
- Page 84 and 85: medicomp GmbHCROContact:Dr. med. ve
- Page 86 and 87: Contact:Dr. Erwin SoutschekFlorians
- Page 88 and 89: MLL Münchner Leukämie Labor GmbHB
- Page 90 and 91: multimmune GmbHBIOTECH THERAPEUTICS
- Page 92 and 93: NanoScape AGPHARMA & CHEMICAL INDUS
- Page 94 and 95: nexttec GmbHBIOTECH DNA/PROTEIN ANA
- Page 96 and 97: Contact:Michael AlmstetterAm Klopfe
- Page 98 and 99: PAN Biotech GmbHBIOTECH DEVICES & R
- Page 100 and 101: Pharma Stulln GmbHPHARMA & CHEMICAL
- Page 102 and 103: Phytochem Referenzsubstanzen GbRmbH
- Page 104 and 105: PreSens Precision Sensing GmbHBIOTE
Emergent Product DevelopmentGermany GmbHBIOTECH DNA/PROTEIN ANALYTICSKeywords: Vaccines, Infectious DiseasesEmergent <strong>Bio</strong>Solutions protects and enhances life by developing and manufacturingvaccines and therapeutics that are supplied to healthcare providersand purchasers for use in preventing and treating disease. Emergent‘smarketed and investigational products target infectious diseases, oncologyand autoimmune disorders.Contact:Isabelle ErdeljiWalter-Gropius-Str. 17D-80807 MünchenPhone: +49 (0) 89 5506988-0Fax: +49 (0) 89 5506988-88E-Mail: erdeljii@ebsi.comInternet: www.emergentbiosolutions.comEMP GenetechBIOTECH DNA/PROTEIN ANALYTICSKeywords: Peptide/Protein, Clinical Diagnostics, Tissue Engineering / CellCulture, Drug DevelopmentEMP Genetech conducts development and production of recombinant proteinsas a service provider for research departments in industry and academia.For production HEK293 (hn embryonic kidney) cells are being used. Thesecells are distinguished for the expression of glycosilated, correctly processedand modified proteins. The expressed proteins show excellent bioactivitycompared to other expression systems. The biomolecules are produced inserum free culture medium of safe origin. EMP Genetech offers all workingsteps from cloning of the GOI to chromatographic purification of the producedprotein. There are developed stable cell lines of high productivity. Theseare cultivated as suspension cell cultures in stirred bioreactors usually in acontinous mode. The expression product is purified from cell supernatant orcell extract by classical column chromatographic methods. The bioactivitywill be analysed by enzymatic or cell assays.Contact:Dr. Franz X. WelserHebbelstr. 61D-85055 IngolstadtPhone: +49 (0) 841 3796013Fax: +49 (0) 841 8817185E-Mail: info@empgenetech.comInternet: www.empgenetech.comEntelechon GmbHBIOTECH DNA/PROTEIN ANALYTICSKeywords: Proteomics, Clinical Research, Chip / Array Technology, PCR,Genomics, Antibody Production ServiceEntelechon is a globally operating service provider specialized in advancedgenomics and proteomics projects. Success factor: Leveraging full potentialof gene and protein synthesis platforms as well as synergy of biochemistry,molecular biology and bioinformatics for implementation of complex projects.Services: Gene optimization and synthesis, protein expression invarious systems, protein analysis and quantification, design and synthesisof gene mutant libraries, bioinformatics software development.Applications: Preclinical stage drug discovery; protein engineering and production;development of therapeutic proteins, antibodies, vaccines, industrialenzymes; downstream biotech services; multiple profile research projects.Contact:Dr. Werner DeiningerIndustriestr. 1D-93077 Bad AbbachPhone: +49 (0) 9405 96999-10Fax: +49 (0) 9405 96999-28E-Mail: info@entelechon.comInternet: www.entelechon.com57